Related Experiment Video
Updated: Oct 2, 2026
Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
[Can immunoradiometric measurement of thyrotropin (TSH) in human serum compete with a luminometric assay?]
K Zöphel1, J Pinkert, G Wunderlich
1Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden, Deutschland. kzophel@rcs.urz.tu-dresden.de
Unlabelled:
The development of highly sensitive, nonradioimmunometric assays for the measurement of thyrotropin (TSH) during the last few years have improved the measurement of low TSH values and thus benefit the diagnosis of thyroid function disorders. These third or fourth generation assays are especially popular in laboratories not accustomed to the use of radioactive tracers and can be easily automatized.
Aim:
This study investigates whether these new assays provide an advantage in routine diagnosis of thyroid disorders.
Methods:
TSH was measured in 150 patients with various thyroid pathology using an immunoradiometric assay (IRMA) as well as a highly sensitive luminometric assay (LUMI), both by B.R.A.H.M.S. Diagnostica. We used the current modern IRMA (available since 1997) TSH was below 0.4 mU/l, between 0.4 and 4.0 mU/l, and above 4.0 mU/l in a third of the patients in each group, respectively.
Results:
As expected the results obtained with LUMI and IRMA correlated well for TSH values above 0.1 mU/l and less well between 0.1 and 0.01 mU/l. There was no correlation between the two types of assay at TSH concentrations below 0.01 mU/l. This shows that measurements using both types of assay become increasingly less precise below 0.1 mU/l.
Conclusion:
Both types of assay gave an identical estimate of thyroid function in every single patient. Use of the LUMI did not give additional information leading to a change in patient management. Therefore, TSH measurement using IRMA does still meet today's routine clinical requirements.
